» Articles » PMID: 14993493

Natural History of Parathyroid Function and Calcium Metabolism After Kidney Transplantation: a Single-centre Study

Overview
Date 2004 Mar 3
PMID 14993493
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The natural history of parathyroid function after successful renal transplantation (RT) and the factors predisposing to persistent hyperparathyroidism (HPT) are not well established. A better knowledge of these data may be helpful in the development of algorithms for optimal surveillance and treatment of HPT after successful RT. Our aim was to evaluate the post-transplant natural history of parathyroid function and calcium metabolism in patients with a functional renal graft and to identify risk factors for persistent HPT.

Methods: Charts of 1165 allograft kidney recipients transplanted between 1989 and 2000 were reviewed. Patients with an intact parathyroid hormone (iPTH) level available at the time of transplantation were identified. The charts of the latter patients were checked for a variety of demographic and clinical data, and all determinations of the iPTH concentration available since transplantation were recorded. Serum levels of calcium, phosphorus, alkaline phosphatases and creatinine, concurrently determined, were also registered.

Results: After an initial fall, iPTH levels showed a slow but steady decline towards the upper normal limit. The prevalence of persistent HPT, defined as an iPTH level > or =2.5 times the upper normal limit or the need for parathyroidectomy following transplantation, remained stable at approximately 17% up to 4 years after transplantation. Patients with persistent HPT had significantly elevated serum levels of iPTH, calcium and phosphorus at the time of RT, and had spent a longer time on dialysis. Post-transplant iPTH levels correlated significantly with transplant kidney function.

Conclusion: Kidney transplant recipients with a high iPTH and calcium x phosphate product at the time of transplantation are at risk for persistent HPT especially when renal function is suboptimal. Therapy for persistent HPT, if considered, should be initiated 3 months post-transplantation since further spontaneous improvement of parathyroid function thereafter is limited.

Citing Articles

Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation.

Delaey P, Devresse A, Morelle J, Faitatzidou D, Iriarte M, Kanaan N Kidney Int Rep. 2024; 9(7):2146-2156.

PMID: 39081745 PMC: 11284412. DOI: 10.1016/j.ekir.2024.04.004.


Secondary Hyperparathyroidism and Cognitive Decline.

Crepeau P, Fedorova T, Morris-Wiseman L, Mathur A Curr Transplant Rep. 2024; 10(2):60-68.

PMID: 38707996 PMC: 11068066. DOI: 10.1007/s40472-023-00394-5.


Outcome of surgical parathyroidectomy for tertiary hyperparathyroidism in kidney transplant recipients: tertiary hyperparathyroidism should not be ignored, for the sake of precious allografts.

Nakamura M, Takiguchi S, Uehara S, Tomita Y Ren Fail. 2024; 46(1):2333919.

PMID: 38575330 PMC: 10997355. DOI: 10.1080/0886022X.2024.2333919.


Pre-Transplant Hyperparathyroidism and Graft or Patient Outcomes After Kidney Transplantation.

Rodrigues F, van der Plas W, Sotomayor C, Van der Vaart A, Kremer D, Pol R Transpl Int. 2024; 37:11916.

PMID: 38384325 PMC: 10880800. DOI: 10.3389/ti.2024.11916.


Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management.

Teh J, Mac Gearailt C, Lappin D Int J Mol Sci. 2024; 25(3).

PMID: 38339137 PMC: 10856017. DOI: 10.3390/ijms25031859.